"Arcus and AstraZeneca enter trial collaboration for renal cancer treatment" was originally created and published by Clinical ...

FixMap is an “M&A machine” and the leading player in the Polish fiber-to-the-home (FTTH) market by far, thanks to the ...

Arcus Power, an energy intelligence company, today announced a strategic partnership with weather tech pioneer Climavision, ...

US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

Arcus Biosciences Inc (RCUS) stock saw a decline, ending the day at $15.31 which represents a decrease of $-0.08 or -0.52% from the prior close of $15.39. The stock opened at $15.19 and touched a low ...

DTCP has invested in Atlantic Hub, a data center developer in Ireland, spotting an opportunity away from more well-trodden ...

Wednesday announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan in combination with volrustomig for the treatment of clear cell renal cell carcinoma or ccRCC ...

CALGARY, AB, Oct. 2, 2024 /PRNewswire/ - Arcus Power, an energy intelligence company, today announced a strategic partnership with weather tech pioneer Climavision, to integrate their Horizon AI ...

HAYWARD, Calif. - Arcus Biosciences, Inc. (NYSE:RCUS) and AstraZeneca (LSE/STO/Nasdaq: NASDAQ:AZN) have entered into a clinical trial collaboration to evaluate a new combination therapy for the ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

Arcus Biosciences develops late-stage immunotherapies, with Domvanalimab and Casdatifan leading the way. See why I rate RCUS ...